Institute of Medical Biometry and Statistics, Medical Data Science, Faculty of Medicine and Medical Center, University of Freiburg, 79104 Freiburg, Germany.
Private Practice, Münster, Germany and Department of Oral and Maxillofacial Plastic Surgery and Implantology, University of Cologne, 50932 Köln, Germany.
Int J Mol Sci. 2020 Jul 17;21(14):5043. doi: 10.3390/ijms21145043.
This systematic review aimed to assess the effectiveness of xenogeneic collagen matrices (XCMs) and acellular dermal matrices (ADMs) in comparison to connective tissue grafts (CTGs) for the augmentation of oral mucosa around dental implants. MEDLINE and the Web of Science were searched for clinical studies that compared substitute materials for the augmentation of oral mucosa to the subepithelial connective tissue graft around dental implants during or after implantation. The review was conducted according to the recommendations of the PRISMA statement. From an initial search result set of 1050 references, seven articles were included in the review. The study designs were heterogeneous, so no meta-analysis could be performed. Both the CTG and either type of substitute material resulted in increased mucosal thickness. Four studies showed no significant difference, while three demonstrated a significant difference, favoring the CTGs over alternative materials. Soft tissue augmentation around dental implants is a safe procedure and leads to thicker mucosal tissue. The subepithelial connective tissue graft can still be regarded as the gold standard, but substitute materials may be an acceptable alternative in some situations, such as for pain-sensitive patients, among inexperienced surgeons, and for sites with an already thick biotype.
本系统评价旨在评估异种胶原基质(XCM)和去细胞真皮基质(ADM)与结缔组织移植物(CTG)相比,在种植牙周围口腔黏膜增强方面的效果。通过 MEDLINE 和 Web of Science 检索了将替代材料用于种植牙周围口腔黏膜增强,并与种植体植入期间或之后的上皮下结缔组织移植物进行比较的临床研究。本综述是根据 PRISMA 声明的建议进行的。从最初的 1050 篇参考文献中,有 7 篇文章被纳入综述。研究设计存在异质性,因此无法进行荟萃分析。CTG 和任何一种替代材料都能增加黏膜厚度。四项研究显示无显著差异,而三项研究则表明存在显著差异,CTG 优于替代材料。种植牙周围的软组织增强是一种安全的手术,可导致黏膜组织更厚。上皮下结缔组织移植物仍然可以被视为金标准,但在某些情况下,替代材料可能是一种可接受的选择,例如对疼痛敏感的患者、经验不足的外科医生,以及已经有较厚生物型的部位。